Credit: Unsplash/CC0 Public Domain The heart is a muscle like no other, beating 60 to 100 times per minute on average, around the clock. But when it grows weak, it can lead to serious problems: from debilitating shortness of breath and swelling in the legs and feet, to fluid in the lungs and even death....
Tag: <span>cardiovascular</span>
Post
Two medication classes found to reduce cardiovascular and liver events in people with type 2 diabetes
JUNE 3, 2024 by The Endocrine Society Credit: Unsplash/CC0 Public DomainGLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data presented at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. “Before this study, there...
Post
Dark Chocolate: A Delicious Ally in Cardiovascular Health By: BNN Correspondents The old adage, “Let food be thy medicine” finds a contemporary affirmation in recent scientific findings that link the consumption of dark chocolate to a reduction in the risk of future cardiovascular diseases. The rich, bittersweet treat, often enjoyed with a cup of coffee, is...
Post
Once again, Novo’s semaglutide shows cardiovascular benefit, weight loss — this time in adults with heart failure
Katherine Lewin | News Reporter Novo Nordisk’s GLP-1 Wegovy has shown cardiovascular benefit again, this time in the Phase III STEP HFpEF trial, on top of the expected weight loss, the company announced at the European Society of Cardiology (ESC) Congress today. Against placebo, 2.4 mg of Wegovy (semaglutide) showed “large” reductions in heart failure-related...
Post
Tiny heart model offers game-changing potential for drug testing and cardiovascular disease treatments
by Hebrew University of Jerusalem Hand with microchip. Credit: Tissue Dynamics In a remarkable breakthrough, a collaborative team of researchers, led by Professor Yaakov Nahmias from The Hebrew University of Jerusalem, Technion-Israel Institute of Technology, and Tissue Dynamics Ltd., has unveiled a miniature human heart model that could potentially transform drug testing and cardiovascular research. This...
Post
Investigating the laterality of blood pressure regulation during cardiovascular disease progression
by Thamarasee Jeewandara, Medical Xpress A schematic illustration of the lateralization during aortic baroreflex function. Credit: Journal of Hypertension (2023). DOI: 10.1097/HJH.0000000000003448 The outcomes of blood pressure regulation provide a clear picture of the underlying mechanisms of the arterial baroreflex, a critical cardiovascular reflex, during health and disease. Under normal blood pressure, the functional difference can vary between...
Post
Dietary recommendations for cardiovascular health challenged by new evidence on saturated fatty acids’ effects on LDL-C and Lp(a) levels
A recent perspective piece published in The American Journal of Clinical Nutrition discussed current dietary recommendations to reduce the intake of saturated fatty acids and modulate the risk of cardiovascular disease while highlighting the impact of lower saturated fatty acid intake on low-density lipoprotein cholesterol (LDL-C) and lipoprotein A. Study: Lipoprotein(a) and Diet – A Challenge...
Post
Researchers shed new light on damaging effects of standard heart attack treatment
by Indiana University School of Medicine Credit: Pixabay/CC0 Public Domain A study led by Indiana University School of Medicine is challenging standard treatment methods used to prevent muscle damage during heart attack. In a paper published in the Journal of the American College of Cardiology, Rohan Dharmakumar, Ph.D. asserts that a common treatment given to patients experiencing heart attack may...
Post
FAST study finds no increased risk of cardiovascular events with febuxostat as compared with allopurinol for gout
by University of Glasgow Gout in X-ray of left foot. A major new study examining the relative safety of medicines for the treatment of gout will be presented at the American College of Rheumatology Convergence conference and will be published in The Lancet. The FAST Study finds no increased risk of cardiovascular events with febuxostat as compared...
Post
Research pinpoints sources of atrial fibrillation
by Amy Colgan, The Ohio State University People who suffer from persistent atrial fibrillation in the heart may find relief from a new treatment approach discovered by researchers at The Ohio State University Davis Heart and Lung Research Institute. Atrial fibrillation is an irregular heartbeat, or a condition in which the atria fail to contract in a strong, rhythmic way....